Many patients with severe gastroparesis unfortunately do not achieve adequate relief from the previously outlined therapies. In such cases, consideration should be given to implantation of a ...

In addition to treating symptoms, prokinetic drugs could potentially improve glycemic control in diabetic gastroparesis by allowing a more predictable absorption of nutrients, matched to the ...

Most of the time, doctors say, gastroparesis will improve after stopping the medication. But some people say that their ...

Experts say while gastroparesis isn’t very common, it can develop due to the use of specific medications prescribed for managing diabetes and weight loss. Gastroparesis, also known as delayed ...

Vanda Pharmaceuticals (VNDA) issued a letter to FDA Commissioner highlighting what the company considers a faulty gastroparesis NDA review.

Current research into effective treatments for gastroparesis is focused on agonists of motilin, a peptide hormone that accelerates gastric emptying. McCallum and colleagues studied whether ...

Ltd., Theravance Biopharma Inc., Vanda Pharmaceuticals Inc., and Neurogastrx Inc.. The Gastroparesis Drugs Market is witnessing significant growth due to the rising prevalence of Gastroparesis ...

FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025. Gimoti remains only approved drug shown to reduce hospitalizations, emergency ...

GIMOTI® (metoclopramide) nasal spray remains the sole FDA-approved treatment for diabetic gastroparesis, providing effective symptom relief and substantial cost savings compared to oral ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review.

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) letter to FDA Commissioner highlights faulty gastroparesis NDA review. As ...